Staar Surgical (STAA) EBIT Margin (2010 - 2026)
Staar Surgical's (STAA) quarterly EBIT Margin came in at 10.8% in Q3 2026, up 7841.0% on a YoY basis from 0.14% in Q3 2025, and up 26.58% quarter-over-quarter from 8.53% in Q2 2026.
Powered by 
Analysis
Staar Surgical (STAA) EBIT Margin (2010 - 2026) Analysis & Trends
Staar Surgical (STAA) has reported EBIT Margin for 17 consecutive years, with 10.8% the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, EBIT Margin rose 7841.0% year-over-year to 10.8%; the trailing twelve-month figure through Jul 2026 stood at 4.04% (up 5287.0% YoY), and the FY2026 full-year result was 38.3%, down 3429.0% from the prior year.
- EBIT Margin rose to 10.8% in Q3 2026 per STAA's latest filing, from 8.53% in the prior quarter.
- Across five years, EBIT Margin topped out at 20.99% in Q3 2022 and bottomed at 134.78% in Q1 2025.
- Historically, EBIT Margin has averaged 8.15% across 5 years, with a median of 8.19% in 2023.
- The sharpest annual moves came in 2025 and 2026: EBIT Margin sank 13183 bps in 2025, then jumped 14331 bps in 2026.
- Over 5 years, EBIT Margin stood at 5.05% in 2022, then surged by 170 bps to 13.64% in 2023, then slumped by 518 bps to 57.02% in 2024, then jumped by 134 bps to 19.52% in 2025, then slumped by 45 bps to 10.8% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 10.8%, 8.53%, and 39.51% for Q3 2026, Q2 2026, and Q1 2026 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.71 Bn | 174.10 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.20 Bn | 108.38 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 104.00 Bn | 100.53 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.32 Bn | 62.78 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.70 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.88 Bn | 31.43 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.27 Bn | 30.33 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | Staar Surgical | 1.18 Bn | 1.00 Bn | 69.73 Mn | 10.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 10.80% |
| Apr 3, 2026 | 8.53% |
| Jan 2, 2026 | -39.51% |
| Sep 26, 2025 | 19.52% |
| Jun 27, 2025 | -67.61% |
| Mar 28, 2025 | -134.78% |
| Dec 27, 2024 | -57.02% |
| Sep 27, 2024 | 6.41% |
| Jun 28, 2024 | 12.02% |
| Mar 29, 2024 | -2.95% |
| Dec 29, 2023 | 13.64% |
| Sep 29, 2023 | 7.84% |
| Jun 30, 2023 | 9.31% |
| Mar 31, 2023 | 3.81% |
| Dec 30, 2022 | 5.05% |
| Sep 30, 2022 | 18.02% |
| Jul 1, 2022 | 20.99% |
| Apr 1, 2022 | 19.17% |
| Dec 31, 2021 | 12.51% |
| Oct 1, 2021 | 13.43% |